Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups,… Continue Reading

ESCAPE-NET project aims to improve SCA management

ESCAPE-NET project aims to improve SCA management

Sudden cardiac arrest (SCA) causes ~20% of all deaths in Europe. SCA is lethal within minutes if left untreated and survival rates are presently only 5-20%. Therefore, there is a large medical need to improve SCA prevention and treatment.

Epithydia proposal ranks 1st out of 300 in Eurostars application

Epithydia proposal ranks 1st out of 300 in Eurostars application

The grant proposal written by Catalyze for the Epithydia project ranked 1st out of 300 applications.

COST Actions for ‘good biomarker practice’

COST Actions for ‘good biomarker practice’

COST funds pan-European, bottom-up networks of scientists and researchers across all science and technology fields. These networks, called ‘COST Actions’, promote international coordination of nationally-funded research.

ICENESS tube solution for cryopreserved biosamples

ICENESS tube solution for cryopreserved biosamples

Freeze-thawing cycles are disastrous for cryopreserved biosamples. The frozen ICENESS tube can be subdivided in to sections to circumvent this problem.

Imaging agent to determine colorectal cancer relapse

Imaging agent to determine colorectal cancer relapse

META-DETECT will develop a multi-target imaging agent to diagnose, stage and determine the risk of relapse in colorectal cancer (CRC).

Novel therapeutic antibody

Novel therapeutic antibody

NOVA-CARE aims to establish preclinical efficacy in mouse and porcine disease models for a novel therapeutic monoclonal antibody (mAb) to prevent non-ischaemic heart failure (NI-HF) by targeting EDA-fibronectin (EDA).

Highest Rated Eurostars Project

Highest Rated Eurostars Project

Dutch start-up Nutrileads and 4 partners from the Netherlands, Germany and Finland were awarded a € 2 million Eurostars project called NIMF. The NIMF project was the highest rated project with a Dutch participant, ranking 4th of 269 applications across all fields in Europe.

Next-generation allergy vaccine

Next-generation allergy vaccine

The TARGIT project will develop a next-generation allergy vaccine to treat grass-pollen induced allergic rhinitis and asthma effectively and life-long. The vaccine is based on unique glycans, covalently linked to clinically relevant grass pollen derived peptides.

 

Welcome at Catalyze!

Catalyze uses cookies in order to improve your user experience. By using this website you agree to our policy.

Go back or